News

Drug-Eluting Stents Favored in ST-Elevation MI

Publish date: May 1, 2008
PDF Download

 

In the same trial, tirofiban was found noninferior to abciximab in resolving ST elevation at 90 minutes. DR. VALGIMIGLI

Pages

Recommended Reading

Peripheral Artery Stents Cut Amputation Rates, Medical Costs
MDedge Cardiology
Polymer-Coated Stent Shows Promise in First Test
MDedge Cardiology
TRITON Analysis: Prasugrel Curbs Second MI
MDedge Cardiology
Aspiration During PCI Improves Reperfusion
MDedge Cardiology
Guidance Offered on Cocaine-Related Chest Pain
MDedge Cardiology
AHA Calls for Glucose Control in ACS Patients With Hyperglycemia
MDedge Cardiology
Angina and Dementia Are Linked in Study of Twins
MDedge Cardiology
Correcting Hypertension Cuts Poststroke Deaths
MDedge Cardiology
BP Protocol Violations in Stroke May Raise Risk of Hemorrhage
MDedge Cardiology
Stroke Patients on Antiplatelet Drugs May Benefit From TPA
MDedge Cardiology